Increased expression of pro-apoptotic proteins Bax, cleaved caspase-3, and cleaved PARP; in addition, decreased expression of anti–apoptotic protein Bcl-2 (Fig. 5i) clearly demonstrate that nimbolide treatment inhibits pancreatic cancer growth by inducing apoptosis. Here, BCL2 is linked to pancreatic neoplasm.